Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Reece

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|September 1, 1990
Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host diseaseH G Klingemann, M J Barnett, D E Reece, et al.
Bone Marrow Transplantation|October 28, 2014
Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agentsV H Jimenez-Zepeda, D E Reece, S Trudel, et al.
Bone Marrow Transplantation|March 21, 2000
Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresisG A Hale, D E Reece, R K Munn, et al.
Current Oncology (Toronto, Ont.)|August 5, 2014
Bortezomib in multiple myeloma: systematic review and clinical considerationsT C Kouroukis, F G Baldassarre, A E Haynes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2013
Bortezomib in multiple myeloma: a practice guidelineC T Kouroukis, F G Baldassarre, A E Haynes, et al.
Annals of Internal Medicine|December 1, 1989
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?S L Sacks, R J Wanklin, D E Reece, et al.
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Leukemia Research|January 1, 1986
Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemiaD E Reece, N A Buskard, R S Hill, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|September 1, 1990
Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host diseaseH G Klingemann, M J Barnett, D E Reece, et al.
Bone Marrow Transplantation|October 28, 2014
Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agentsV H Jimenez-Zepeda, D E Reece, S Trudel, et al.
Bone Marrow Transplantation|March 21, 2000
Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresisG A Hale, D E Reece, R K Munn, et al.
Current Oncology (Toronto, Ont.)|August 5, 2014
Bortezomib in multiple myeloma: systematic review and clinical considerationsT C Kouroukis, F G Baldassarre, A E Haynes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 2013
Bortezomib in multiple myeloma: a practice guidelineC T Kouroukis, F G Baldassarre, A E Haynes, et al.
Annals of Internal Medicine|December 1, 1989
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?S L Sacks, R J Wanklin, D E Reece, et al.
Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantationT J Nevill, M J Barnett, H G Klingemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantationJ D Shepherd, L E Pringle, M J Barnett, et al.
Leukemia Research|January 1, 1986
Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemiaD E Reece, N A Buskard, R S Hill, et al.
Pageof 8